Brief: Xilio Therapeutics Reports Pipeline And Business Progress And Fourth Quarter And Full Year 2021 Financial Results
01/03/2022 11:54
March 1 (Reuters) - Xilio Therapeutics Inc XLO.O :
* XILIO THERAPEUTICS REPORTS PIPELINE AND BUSINESS PROGRESS
AND
FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS
* XILIO THERAPEUTICS INC - CONTINUE TO ANTICIPATE CASH
RUNWAY INTO
2024 WITH $198.1 MILLION IN CASH AND CASH EQUIVALENTS AT
YEAR-END 2021
* XILIO THERAPEUTICS INC- QTRLY LOSS PER SHARE $0.98
Source text for Eikon: ID:nGNX8VsyTQ
Further company coverage: XLO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla